Tandem
Category: AI in Healthcare
An AI-driven operating system for medical prescriptions that automates the end-to-end workflow between doctors, insurance payers, and pharmacies. Tandem was founded in 2023. The company is led by Sahir Jaggi. Based in New York, USA. Team size: 11-50. Total funding raised: Undisclosed. Latest round: Acquired by Vensure (Jul 2024) - price not disclosed. Key investors include ["Thrive Capital","Pear VC","BoxGroup","Mario Schlosser"].
- Founded
- 2023
- Headquarters
- New York, USA
- Team size
- 11-50
- Total funding
- Undisclosed
Value proposition
Reduces the medication wait time from weeks to hours by automating the prior authorization process and clinical documentation, significantly lowering administrative burnout and improving patient adherence.
Products and solutions
["AI Prior Authorization Engine","Automated Pharmacy Coordination Platform","Clinical Documentation & Scribe Tools","Payer Rule Intelligence Dashboard","Patient Medication Access Tracker"]
Unique value
Unlike generic AI scribes, Tandem focuses specifically on the 'last mile' of care—ensuring the prescription is actually filled by navigating the complex intersection of clinical intent and insurance restrictions.
Target customer
Healthcare providers, specialty medical clinics, health systems, and clinical administrative staff.
Industries served
["Healthcare Technology","Health Insurance (Payers)","Pharmaceuticals","SaaS (Healthtech)"]
Technology advantage
Leverages proprietary Large Language Models (LLMs) trained on complex payer-provider data schemas. The leadership team’s deep background at Oscar Health provides a unique 'insider' understanding of insurance adjudication logic that is difficult for competitors to replicate.
How they differentiate
Tandem differentiates by focusing on the 'last mile' of the prescription process. While competitors often focus on general clinical documentation or simple electronic prior authorizations, Tandem uses proprietary LLMs to navigate the complex intersection of clinical intent and specific insurance adjudication logic to ensure medications are actually dispensed.
Main competitors
["CoverMyMeds","Cohere Health","Ambience Healthcare","PriorAuthNow"]
Key partnerships
["Thrive Capital","Pear VC","BoxGroup","Strategic alignment with Oscar Health ecosystem (via founder Mario Schlosser)"]
Notable customers
["Oscar Health (Strategic Partner)","Specialty Medical Groups","Large-scale Health Systems"]
Major milestones
["Founded in 2023 by former Oscar Health product lead Sahir Jaggi","Successfully automated the 'last mile' of prescription fulfillment, reducing wait times from weeks to hours","Achieved a $1 billion valuation in January 2026"]
Growth metrics
Reached Unicorn status with a $1 billion valuation within three years of founding; expanded from initial pilot clinics to enterprise-scale health system deployments.
Market positioning
Premium AI-infrastructure provider for specialty clinics and large health systems, positioning itself as the 'intelligent operating system' for prescription workflows.
Geographic focus
United States (specifically targeting the complex US payer-provider insurance landscape).
Patents and IP
No specific public patent filings disclosed; relies on proprietary algorithms and trade-secret data processing workflows.
About Sahir Jaggi
Sahir Jaggi is a seasoned healthtech leader with over 6 years at Oscar Health, where he rose to Director of Product Strategy. He played a pivotal role in building Oscar's care delivery and patient experience infrastructure. His background combines technical expertise (Biomedical Engineering/CS from Columbia) with venture experience as a Partner at Rough Draft Ventures.
Official website: https://withtandem.com/